This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Life Sciences Accounting & Reporting Congress
March 23-25, 2026
Hilton at Penn's LandingPhiladelphia, PA

Frank Panaro
Director, Finance Valuation and Business Case at Bayer
Speaker

Profile

Frank has been in Pharma/Biotech for over 20 years, with 8 years in the lab as a Molecular Biologist and over 15 years in Finance, supporting all areas of the business from R&D through Commercial. He holds a Bachelor of Science in Biology from Siena University, a Master of Science Degree in Molecular Biology from NYU and an MBA in Finance from Pace University. Frank's prior roles before joining Bayer include Director of Corporate Finance at Sunovion, Director of Commercial Finance at bluebird bio, Director of Gross to Net Finance at Purdue, and Associate Director of Forecasting US Oncology at Boehringer Ingelheim.

Agenda Sessions

  • Financial Reporting Considerations When Transitioning From Clinical to Commercial

    4:30pm